Endobronchial Ultrasound Biopsy Market Research Report Information By Product (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Transbronchial Aspiration Needles, Spray Catheters, and Others), By Application (Cancer Diagnosis, Infection Diagnosis, and Others), By End-user (Hospitals, Ambulatory Surgical Centers, Cancer Specialty Clinics, Diagnostics Centers, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Global Endobronchial Ultrasound Biopsy Market Overview

Endobronchial Ultrasound Biopsy Market Size was valued at USD 0.7 Billion in 2023. The Endobronchial Ultrasound Biopsy market industry is projected to grow from USD 0.72 Billion in 2024 to USD 1.01 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.00% during the forecast period (2024 - 2032). Diseases that necessitate endoscopic ultrasound procedures are becoming more prevalent at an escalating rate, which is one of the key market drivers boosting the expansion of the market.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Endobronchial Ultrasound Biopsy Market Trends

• 
  

  Growing use of endoscopic ultrasound procedures to diagnose a growing number of diseases is driving the market growth

  
  

Market CAGR for Endobronchial Ultrasound Biopsy is being driven by the increasing advantages of ultrasound biopsy devices. Endobronchial ultrasound (EBUS) is an ultrasound modality utilized to evaluate neoplastic metastasis to remote anatomical locations, such as lymph nodes, and to diagnose stage-specific lung cancer. This particular brand of ultrasound is utilized in a minimally invasive procedure to procure tissue samples for biopsy.

Additionally, the increasing benefits of endobronchial ultrasound biopsy devices are another factor contributing to the growth of the global market for these instruments. By employing endobronchial ultrasonography biopsies—devices known for their exceedingly high degree of precision—medical personnel are capable of identifying lymph nodes, masses, and lung nodules. Additionally, it may enable a more efficient and effective course of action by facilitating the distinction between benign and malignant lesions.

Significant allocations of resources toward research and development for groundbreaking technological advancements are creating a growing market opportunity. For example, endobronchial ultrasound biopsy-TBNA tissue samples of superior quality are in increasing demand in order to achieve these goals. Subsequently, new challenges have emerged and technical prerequisites have increased. Prospects for market expansion in the endobronchial ultrasound biopsy industry will result from the expanding adoption of this technique and the rising investments in medical devices and instruments by both developed and developing countries in response to the rising prevalence of chronic diseases like lung cancer. An increasing demand exists for novel and innovative technologies capable of precise diagnosis, owing to the prevalence of diverse types of infections. Innovations in product development, such as transbronchial aspiration instruments, and increased investments in healthcare infrastructure contribute to the expansion of the endobronchial ultrasound biopsy vertical. Because of this, manufacturers must invest in R&D to satisfy rising demand and create innovative, improved products. For instance, in 2021, 10.6 million people worldwide were estimated to have contracted tuberculosis (TB), according to a WHO update from October 2022. A common causative agent of tuberculosis (TB), endobronchial tuberculosis (EBTB), is the tracheobronchial tree-infecting Mycobacterium tuberculosis. Thus, result in driving the Endobronchial Ultrasound Biopsy market revenue.

Endobronchial Ultrasound Biopsy Market Segment Insights

Endobronchial Ultrasound Biopsy Product Insights

The Endobronchial Ultrasound Biopsy Market segmentation, based on Product, includes Biopsy Forceps, Cytology Brushes, Biopsy Needles, Transbronchial Aspiration Needles, Spray Catheters, and Others. The transbronchial aspiration needles segment dominated the market in 2023. Transbronchial aspiration needles are utilized to extract tissue from lung, hilar, or mediastinum lesions. Placing the intended lesion is facilitated through the use of a bronchoscopy (lung mass or lymph node examination). Following the catheter and needle passage of the bronchoscope's working channel through the bronchial wall, the substance is subsequently evacuated for bacteriological, cytological, or histological examination.

Endobronchial Ultrasound Biopsy Application Insights

The Endobronchial Ultrasound Biopsy Market segmentation, based on Application, includes Cancer Diagnosis, Infection Diagnosis, and Others. The category with the highest revenue in 2023 was Cancer Diagnosis. Market expansion is aided by the increased demand for minimally invasive medical procedures and the increased adoption of these procedures by diagnostic departments of healthcare institutions (e.g., medical clinics, diagnostic centers) and interventional radiologists for the purpose of disease diagnosis.

Figure 1: Endobronchial Ultrasound Biopsy Market, by Application, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Endobronchial Ultrasound Biopsy End-user Insights

The Endobronchial Ultrasound Biopsy Market segmentation, based on End-User, includes Hospitals, Ambulatory Surgical Centers, Cancer Specialty Clinics, Diagnostics Centers, and Others. Hospitals emerged as the dominant market segment in 2023. An upward trend in the number of government and private hospitals in emergent economies such as China and India, in addition to a rise in the number of EBUS procedures performed in hospitals, contributes to the hospitals segment's dominance.

Endobronchial Ultrasound Biopsy Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Endobronchial Ultrasound Biopsy market area will dominate this market. Demand for endobronchial ultrasonography biopsies to diagnose lung cancer has increased due to the region's accelerated economic expansion, which has led to a rise in industrial production.

Further, the major countries studied in the market report are Brazil, South Korea, China, Japan, India, Australia, Germany, France, the UK, Italy, Spain, Canada, and the US.

Figure 2: ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET SHARE BY REGION 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Endobronchial Ultrasound Biopsy market has the second-largest portion of the market. Lung cancer rates have risen in tandem with technological progress. Further, the German Endobronchial Ultrasound Biopsy market had the biggest market share, and the UK Endobronchial Ultrasound Biopsy market was the European market with the quickest rate of growth.

The Asia-Pacific Endobronchial Ultrasound Biopsy Market is anticipated to expand between 2024 and 2032 at the quickest CAGR. As a result of the region's accelerated economic expansion, industrial output has increased. Moreover, China’s Endobronchial Ultrasound Biopsy market had the biggest market share, and the Indian Endobronchial Ultrasound Biopsy market was the Asia-Pacific region's fastest-growing market.

Endobronchial Ultrasound Biopsy Key Market Players & Competitive Insights

Leading market players are putting a lot of money into research and development to expand their product lines, which will drive the market for Endobronchial Ultrasound Biopsy to expand even further. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, the Endobronchial Ultrasound Biopsy industry must provide reasonably priced goods.

Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the global Endobronchial Ultrasound Biopsy industry to help customers and expand the market segment. In recent years, the Endobronchial Ultrasound Biopsy industry has provided some of the biggest benefits to medicine. Major players in the Endobronchial Ultrasound Biopsy market, including Olympus Corporation, Medtronic, Cook Medical, CONMED Corporation, CLINODEVICE, and others, are engaging in research and development activities in an effort to boost market demand.

The Irish company Medtronic plc produces medical devices. The legislative headquarters of the organization are situated in Ireland, where it acquired the Irish-based company Covidien in 2015. In Minneapolis, Minnesota, the organization maintains its operational and executive headquarters. The organization maintains a global presence spanning more than 150 countries and employs more than 90,000 individuals despite its primary operational headquarters being situated in the United States. Pharmaceutical technologies are manufactured and developed by the organization. The organization's intention to pursue a division of the consolidated Patient Monitoring and Respiratory Interventions businesses within its Medical Surgical Portfolio was declared in October 2022.

With interventional radiology, interventional cardiology, peripheral actions, neuromodulation, neurovascular intervention, urology, and gynecology, among others, Boston Scientific Corporation ("BSC") is a multinational manufacturer of medical devices. Founded in Delaware, it has its main office in Watertown, Massachusetts. The Taxus Stent, an intraocular drug-eluting stent that is employed to unclog arteries, is a device for which Boston Scientific has received considerable acclaim. Boston Scientific paid an initial cash payment of $850 million and undisclosed contingent payments contingent on sales performance over the following three years in September 2023 to acquire Relievant Medsystems, Inc.

Key Companies in the Endobronchial Ultrasound Biopsy market include

• Olympus Corporation


• Medtronic


• Cook Medical


• CONMED Corporation


• CLINODEVICE


• Medi-Globe GmbH


• Boston Scientific Corporation

Endobronchial Ultrasound Biopsy Industry Developments

September 2023: The BioStar TBNA Needle, introduced by Broncus Medical in September 2023, provides seamless integration with EBUS procedures and is compatible with both conventional TBNA (CTBNA) and EBUS-enabled TBNA (EBUS-TBNA) diagnostic methods.

May 2021: Olympus introduced the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope in May 2021. FDA 510(k) clearance was granted to this latest addition to the company's extensive EBUS portfolio of needle biopsy devices used for minimally invasive lung cancer staging and diagnosis.

Endobronchial Ultrasound Biopsy Market Segmentation

Endobronchial Ultrasound Biopsy Product Outlook

• Biopsy Forceps


• Cytology Brushes


• Biopsy Needles


• Transbronchial Aspiration Needles


• Spray Catheters


• Others

Endobronchial Ultrasound Biopsy Application Outlook

• Cancer Diagnosis


• Infection Diagnosis


• Others

Endobronchial Ultrasound Biopsy End-user Outlook

• Hospitals


• Ambulatory Surgical Centers


• Cancer Specialty Clinics


• Diagnostics Centers


• Others

Endobronchial Ultrasound Biopsy Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America